Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.
Find University Hospitals Doctors
Neil Korman, MD, PhD

Neil Korman, MD, PhD

  • Director, Clinical Trials Unit, UH Cleveland Medical Center
  • Director, Murdough Family Center for Psoriasis, UH Cleveland Medical Center
  • Professor, CWRU School of Medicine
  • Specialty: Dermatology
  • Location:
    UH Cleveland Medical Center Bolwell
    11100 Euclid Ave
    Cleveland, OH 44106

Biography: Neil Korman, MD, PhD


  • Atopic Dermatitis (Eczema)
  • Blistering Diseases
  • Clinical Trials Research
  • Dermatology
  • Immunotherapy
  • Psoriasis

Certifications & Memberships

  • Clinical and Laboratory Dermatological Immunology - American Board of Dermatology
  • Dermatology - American Board of Dermatology


Fellowship | Dermatology
Dermatology - Clinical Center At The National Institutes Of Health (1987 - 1990)

Residency | Dermatology
Dermatology - University Hospitals Of Cleveland (1985 - 1987)

Internship | Internal Medicine
Internal Medicine - University Hospitals Of Cleveland (1984 - 1985)

Medical Education
Case Western Reserve University School Of Medicine (1984)

Other Education
Case Western Reserve University (1982)

Other Education
Suny Stony Brook University (1977)

Suny Stony Brook University (1976)

Research & Publications

Research Links

View Research

Research Interests

Psoriasis research, Bullous disease research, Translational research

Industry Relationships

University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.

UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.

View UH’s policy (PDF) on practitioner-industry relationships.

As of December 31, 2016, Neil Korman did not disclose any Outside Relationships with Industry.